Koichi Fukunaga to Japan
This is a "connection" page, showing publications Koichi Fukunaga has written about Japan.
Connection Strength
0.130
-
The effect of the outbreak of COVID-19 on respiratory physicians and healthcare in Japan: Serial nationwide surveys by the Japanese Respiratory Society. Respir Investig. 2021 Nov; 59(6):792-798.
Score: 0.022
-
Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan. Virology. 2021 03; 555:35-43.
Score: 0.021
-
Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospective study. J Infect. 2020 11; 81(5):e3-e5.
Score: 0.020
-
Prevalence and clinical characteristics of obstructive- and central-dominant sleep apnea in candidates of catheter ablation for atrial fibrillation in Japan. Int J Cardiol. 2018 06 01; 260:99-102.
Score: 0.017
-
Association between severity of obstructive sleep apnea and glycated hemoglobin level in Japanese individuals with and without diabetes. Endocr J. 2018 Jan 30; 65(1):121-127.
Score: 0.017
-
Subphenotypes of type 2 severe asthma in adults. J Allergy Clin Immunol Pract. 2018 Jan - Feb; 6(1):274-276.e2.
Score: 0.016
-
Allergic bronchopulmonary aspergillosis in Japan: A nationwide survey. Allergol Int. 2018 Jan; 67(1):79-84.
Score: 0.016